Historical record - last NADAC publication: 10/19/2016
Product Information
MORPHINE SULFATE ER 30 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $4.5987 per EA under NDC 00228309011. Its NADAC has been published 179 times since Jun 18, 2014.
The High Outlier badge above means this manufacturer's average price in the Morphine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228309011
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
10/19/2016
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA079040On Market Since
2/4/2014
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 30 MG CAP has been published 179 times since Jun 18, 2014, and over the history we have for it it has declined 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5987 per EA |
|---|---|
| All-time high | $4.9125 (Nov 12, 2014) |
| All-time low | $4.4021 (May 18, 2016) |
| Median price | $4.6822 |
| Average price | $4.6632 |
| Largest weekly change | -9.2% (May 18, 2016) |
| Weeks tracked | 179 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 30 MG CAP, manufactured by Actavis Pharma, Inc., is $4.5987 per EA (NDC 00228309011), effective Nov 15, 2017.
How has the price of MORPHINE SULFATE ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 30 MG CAP has declined 3.7%. It has been tracked across 179 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 30 MG CAP?
Since Jun 18, 2014, the NADAC for MORPHINE SULFATE ER 30 MG CAP has ranged from a low of $4.4021 (May 18, 2016) to a high of $4.9125 (Nov 12, 2014), with a median of $4.6822 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 30 MG CAP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, MORPHINE SULF ER 30 MG TABLET, is $0.4336 per EA — about 91% below MORPHINE SULFATE ER 30 MG CAP.
Who manufactures MORPHINE SULFATE ER 30 MG CAP?
MORPHINE SULFATE ER 30 MG CAP (NDC 00228309011) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification